Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer

BIRMINGHAM, Ala., Feb. 21, 2018 -- (Healthcare Sales & Marketing Network) -- The innovative late development-stage pharmaceutical startup, Bridge Therapeutics®, has named David H. Bergstrom, Ph.D. as its new Chief Operating Officer effective immediate... Biopharmaceuticals, Drug Delivery, Personnel Bridge Therapeutics, buprenorphine, meloxicam, sublingual
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news